Flores-Umanzor, E, Cruz-González, I, Cepas-Guillén, P, Millán, X, Antúnez-Muiños, P, Asmarats, L, Laffond, A, Regueiro, A, López-Tejero, S, Li, CHP, Sanchis, L, Rodés-Cabau, J, Arzamendi, D, Freixa, X. Low-dose direct oral anticoagulation vs dual antiplatelet therapy after left atrial appendage occlusion: 1-year results from the ADALA trial. REVISTA ESPANOLA DE CARDIOLOGIA. 2026; 79(6)DOI:10.1016/j.rec.2025.12.008. PMID:41412468. IF:4.900(Q1/2D).

Trimaille, A, Morel, O, Alperi, A, Veiga-Fernandez, G, Nombela-Franco, L, Vilalta, V, Muñoz-García, A, Nuche, J, Franzone, A, Urena, M, Asmarats, L, Regueiro, A, del Trigo, M, Auffret, V, del Val, D, Serra, V, Carmona, A, Avanzas, P, Fradejas-Sastre, V, Sanchez, I, Trichilo, M, Maneiro, N, Molaro, MI, Fischer, Q, Arzamendi, D, Flores-Umanzor, E, Oteo, JF, Nolf, M, Alfonso, F, Pockels, PD, Elkadiri, C, Cepas-Guillén, P, Avvedimento, M, Rodés-Cabau, J. Prognostic value of early haemodynamic valve deterioration after TAVI. EuroIntervention. 2026; 22(11)DOI:10.4244/EIJ-D-25-01370. PMID:42186872. IF:9.500(Q1/1D).

Cenko, E, Manfrini, O, Yoon, J, Bergami, M, Vasiljevic, Z, Mendieta, G, Zdravkovic, M, Vavlukis, M, Kedev, S, Milicic, D, Ottani, F, Badimon, L, Bugiardini, R. The paradox of SMURF-less outcomes and its implication for diabetes. European Heart Journal-Quality of Care and Clinical Outcomes. 2026; 12(4)DOI:10.1093/ehjqcco/qcag012. PMID:41606783. IF:4.600(Q1/2D).

Bernardo, A, Mato, G, Calandrelli, M, Medus, J, Curiale, A. Parameter-efficient adaptation of foundational models for automated myocardial strain analysis. Biomedical Physics & Engineering Express. 2026; 12(3)DOI:10.1088/2057-1976/ae7c09. PMID:42276109. IF:(Q/D).